Home | My Account | Online Store | Contact & Demand | Press Room | About Us | FAQs
Home
Buy & Subscribe
Special Features
Products & Services
Online Store
Products by category
Products by publisher
Product lines
News Channels
Biotechnology
Therapeutic Areas
Business
RSS Feeds
Free RSS News
Get the latest news direct
to your desktop
feed image

Search in our News Channels

Cheap OEM Software
  

Search in our Online Store
R&D Collaborations
Filter     Order     Display # 
Date Item Title
16 Jun 2008 Alligator Bioscience AB and PolyTherics Ltd announce strategic collaboration for optimisation of next generation biopharmaceuticals
16 Jun 2008 OncoMed Pharmaceuticals Extends License Agreement for Use of MorphoSys's Core Technology
11 Jun 2008 Cellectricon and AstraZeneca - partners in new high throughput ion channel drug discovery technology
10 Jun 2008 Pfizer and UCSF Form Alliance to Advance a Broad Range of Research
10 Jun 2008 Symphogen Enters into strategic collaboration with Genentech for antibody thera-peutics
10 Jun 2008 Astex Announces New Drug Discovery Alliance with Janssen Pharmaceutica N.V.
30 May 2008 Locus Pharmaceuticals Initiates Strategic Inflammatory Cancer Research Collaborations
27 May 2008 Alnylam and Takeda Form Strategic Worldwide Platform Alliance in RNAi TherapeuticsAlnylam and Takeda Form Strategic Worldwide Platform Alliance in RNAi Therapeutics
26 May 2008 GVK BIO enters into Drug Discovery Pact with Wyeth Pharmaceuticals
22 May 2008 Medistem Laboratories, Inc. and Orcist Bio Inc. Enter Into Collaboration Agreement Focused on Augmenting Stem Cell Activity
22 May 2008 ThalesNano Inc. and sanofi-aventis R&D collaborate on continuous process chemistry in order to dramatically reduce drug realization time
21 May 2008 BioSeek to Collaborate with Merck Serono to Assess Potential Drug Candidates
20 May 2008 Five Prime and Pfizer enter Oncology and Diabetes Collaboration
19 May 2008 Schering-Plough Extends Antibody Alliance with MorphoSys
15 May 2008 Medivir AB broadens its Hepatitis C collaboration with Tibotec, entering a partnership in the fiels of HCV Polymerase
12 May 2008 Ranbaxy & Merck Sign Anti-infective Drug Discovery And Development Agreement
08 May 2008 Cytopia announces novel anti-cancer drug development collaboration
08 May 2008 LFB Biotechnologies and GTC Biotherapeutics to collaborate on rhAAT program
07 May 2008 Champions Biotechnology and ImClone Systems Establish Agreement for Preclinical Evaluation of Oncology Drugs
24 Apr 2008 MorphoSys and the Leibniz-Institut für Molekulare Pharmakologie Sign Broad Research Partnership
24 Apr 2008 Arana and Kyowa Hakko to co-develop anti-cancer drug
23 Apr 2008 Metabasis Therapeutics Announces Extension of Its Collaboration with Merck & Co., Inc. to Develop AMPK Activators for Diabetes and Other Metabolic Diseases
22 Apr 2008 Ranbaxy and Orchid announce stragegic business alliance
21 Apr 2008 KINAXO Biotechnologies Enters Agreement with Takeda
17 Apr 2008 GlaxoSmithKline and Regulus Therapeutics form strategic alliance to develop microRNA targeted therapeutics to treat inflammatory diseases
16 Apr 2008 Zelos Therapeutics and Aegis Therapeutics Announce Collaboration for Intranasal Delivery of Zelos’ ZT-031
10 Apr 2008 Jerini Ophthalmic and PR Pharmaceuticals Sign Collaboration Agreement to Develop Sustained-Release Formulations for the Treatment of Eye Diseases
27 Mar 2008 Methylgene announces worldwide research collaboration and license agreement with Otsuka Pharmaceutical co. Ltd.
27 Mar 2008 GTC Biotherapeutics and PharmAthene Extend Agreement for Protexia Program
26 Mar 2008 DAIICHI SANKYO Extends Alliance with MorphoSys for Use of HuCAL GOLD to Develop Novel Antibody Therapies
13 Mar 2008 AstraZeneca signs drug delivery collaboration
12 Mar 2008 BioInvent signs deal with Bayer HealthCare for the discovery and development of therapeutic antibodies
12 Mar 2008 Sirnaomics and GRL Establish Partnership for the Development of Two Multi-Targeted RNAi Therapeutics Products
12 Mar 2008 Prometic announces strategic alliance agreement with Wuhan Institute of Biological Products for the implementation of plasma fractionation technology in China
10 Mar 2008 Dr. Reddy’s Enters Into Drug Discovery Collaboration With 7TM Pharma on Selected Drug Targets
07 Mar 2008 Marcadia Biotech and Merck & Co., Inc. (MRK) Enter Strategic Collaboration
03 Mar 2008 Genmab and Pepscan to Identify Human Antibodies Against Intractable Targets
03 Mar 2008 Neurobiological Technologies, Inc. and Buck Institute Partner to Develop Novel Treatment for Alzheimer's Disease
27 Feb 2008 MorphoSys and Sigma-Aldrich Enter into a Collaboration and Licensing Agreement for Recombinant Research Antibodies
27 Feb 2008 Sangamo BioSciences Announces Expansion of Research and License Agreement With Genentech for ZFP Technology for Protein Pharmaceutical Production
27 Feb 2008 Abbott Laboratories (ABT), Genentech, Inc. (DNA) and WEHI Collaborate to Research and Develop New Anti-Cancer Drugs
27 Feb 2008 Serenex Announces Collaboration With National Cancer Institute to Initiate Clinical Trial With Serenex's Proprietary Small Molecule HSP90 Inhibitor, SNX-5422
21 Feb 2008 MorphoSys and Astellas Extend Alliance for Use of HuCAL GOLD to Develop Novel Antibody Therapies
19 Feb 2008 Biolex Therapeutics Enters Into Agreement With Merck KGaA for Antibody Optimization
15 Feb 2008 NRDL Announces Second Drug Development Agreement with Eli Lilly and Company
12 Feb 2008 Alligator Bioscience and ImmuRx enter into strategic collaboration
07 Feb 2008 Human Genome Sciences and Xencor Announce Genoma Collaboration
04 Feb 2008 Karo bio and Zydus Cadila sign research agreement for development of novel drugs to treat inflammatory diseases
28 Jan 2008 Nicholas Piramal and Pierre Fabre Laboratories sign agreement
28 Jan 2008 Nycomed's Ciclesonide to be Commercialised in the United States by Sepracor
 
<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>
Results 51 - 100 of 530

PipelineReview.com is powered by La Merie Business Intelligence La Merie Business Intelligence

For immediate assistance, please call us during business hours: Mon-Fri 09:00am - 18:30pm; GMT+01

La Merie S.L | Passatge Jordi Ferran, 20 | E-08028 Barcelona | T +34 93 342 91 97 | F +34 93 342 91 98 | Email info@lamerie.com | Internet www.lamerie.com
All contents © by La Merie S. L

Competitor Analysis Series

Diabetes Drug Pipeline

Order Now

Brief Report Series

CD40 and CD40L (CD154) Agonists & Antagonists

Order Now

Subscribe La Merie Biologics